Repeated administration of d-amphetamine induces loss of [123I]FP-CIT binding to striatal dopamine transporters in rat brain: a validation study

Nuclear Medicine and Biology

Volumn 33, Issue 3, 2006, Pages 409-411

  Booij, Jan ^a   de Bruin, Kora ^a   Gunning, W Boudewijn ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

Author keywords

123I FP CIT; Amphetamines; Dopamine transporter; Rats; SPECT

Indexed keywords

DEXAMPHETAMINE; DOPAMINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE; N OMEGA FLUOROPROPYL 2BETA CARBOMETHOXY 3BETA (4 IODOPH ENYL)NORTROPANE I 123; SODIUM CHLORIDE; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASSAY; BODY WEIGHT; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; MALE; NONHUMAN; PROTEIN TRANSPORT; RADIOACTIVITY; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; VALIDATION STUDY;

AMPHETAMINE; ANIMALS; BRAIN; CORPUS STRIATUM; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; IODINE RADIOISOTOPES; MALE; METHAMPHETAMINE; RATS; RATS, WISTAR; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 33646035510     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2005.12.007     Document Type: Article

References (14)

1. 123I]β-CIT SPECT study: preliminary report. Psychopharmacol 159 (2002) 335-340
2. 11C]WIN-35,428. J Neurosci 18 (1998) 8417-8422
3. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M., et al. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 21 (2001) 9414-9418
4. Wagner G.C., Ricaurte G.A., Seiden L.S., Schuster C.R., Miller R.J., and Westley J. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181 (1980) 151-160
5. 123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys. Synapse 27 (1997) 183-190
6. Ricaurte G.A., Fuller R.W., Perry K.W., Seiden L.S., and Schuster C.R. Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine. Neuropharmacology 22 (1983) 1165-1169
7. Wagner G.C., Ricaurte G.A., Johanson C.E., Schuster C.R., and Seiden L.S. Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology 30 (1980) 547-550
8. Kula N.S., and Baldessarini R.J. Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine. Neuropharmacology 30 (1991) 89-92
9. Mintz M., Gordon I., Roz N., and Rehavi M. The effect of repeated amphetamine treatment on striatal DA transporter and rotation in rats. Brain Res 668 (1994) 239-242
10. Armstrong V., Reichel C.M., Doti J.F., Crawford C.A., and McDougall S.A. Repeated amphetamine treatment causes a persistent elevation of glial acidic protein in the caudate-putamen. Eur J Pharmacol 488 (2004) 111-115
11. Shoblock J.R., Sullivan E.B., Maisonneuve I.M., and Glick S.D. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology (Berl) 165 (2003) 359-369
12. Saunders C., Ferrer J.V., Shi L., Chen J., Merrill G., Lamb M.E., et al. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc Natl Acad Sci U S A 97 (2000) 6850-6855
13. Giambalvo C.T. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes. Synapse 49 (2003) 125-133
14. Elfving B., Bjørnholm B., and Knudsen G.M. Interference of anaesthetics with radioligand binding in neuroreceptor studies. Eur J Nucl Med Mol Imag 30 (2003) 912-915